Dottikon ES Holding AG
ISIN: CH0582581713 | Ticker: DESN | LEI: 50670064H782SV8G2Z44
DOTTIKON EXCLUSIVE SYNTHESIS AG manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry.
The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste.
1913
Served areaWorldwide
HeadquartersHembrunnstrasse 17, 5605 Dottikon – Switzerland
13,999,084
IPODec. 4, 2020
Stock exchange(s)SIX Swiss Exchange